Company / Current Assets per Share
Travere Therapeutics, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$5.00
FY2025
5-year range
$5.00 / $11.15
FY2021-FY2025
Trend
-9.5%
vs FY2024
Sector context
#132 of 210
Health Care
What the data says
At $5.00, Travere Therapeutics, Inc.'s current assets per share ranks #132 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 10 years, ranging from $5.00 in FY2025 to $12.59 in FY2018.
Based on SEC 10-K filings.
5.00 in FY2025 with a 5-year CAGR of -12.1%.
Declined from $9.59 to $5.00 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -13.7%
- 5-Year CAGR
- -12.1%
- 10-Year CAGR
- -
Sector benchmark
#132 of 210 in Health CareTop 63% of 210This company $5.00 Sector average $170.65
▼
-97.1% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 9.5% year-over-year.
- Ranks #132 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.00 | -9.5% |
| FY2024 | $5.53 | -42.4% |
| FY2023 | $9.59 | +23.2% |
| FY2022 | $7.78 | -30.2% |
| FY2021 | $11.15 | +17.1% |
| FY2020 | $9.52 | -8.1% |
| FY2019 | $10.37 | -17.7% |
| FY2018 | $12.59 | +46.5% |
| FY2017 | $8.59 | -5.7% |
| FY2016 | $9.11 | -21.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026